Sinopharm Modern (600420.SH) obtained the drug registration certificate for brexpiprazole tablets.

Zhitong Finance APP News, Sinopharm Modern (600420.SH) announced that recently, the company received the "Drug Registration Certificate" for Brexpiprazole Tablets approved and issued by the National Medical Products Administration. Brexpiprazole Tablets are an oral atypical antipsychotic drug, mainly used for the treatment of schizophrenia in adults. The drug regulates neurotransmitters in the brain through multiple mechanisms, including partial agonism of dopamine D2 receptors and 5-HT1A receptors, and antagonism of 5-HT2A receptors, thereby improving psychotic symptoms.